Duchenne muscular dystrophy (DMD) is a progressive, X-linked genetic disorder caused by pathogenic variants in the DMD gene, resulting in absent or markedly reduced dystrophin. The resulting muscle-fibre instability leads to progressive skeletal muscle weakness and can also affect cardiac and respiratory function. Although Ayurvedic interventions have been discussed as potential supportive approaches, they have not been established as disease-modifying treatments for DMD. Any discussion of their role must therefore distinguish traditional therapeutic concepts and preliminary clinical observations from evidence-based standard care.
Ayurvedic understanding of Duchenne muscular dystrophy
From an Ayurvedic perspective, DMD may be interpreted within Adibala Pravritta Vyadhi, a category associated with hereditary disorders arising from abnormalities in Beeja (reproductive elements).
- The concept of Beeja Dushti has been used to describe the hereditary basis of the condition. Predominance and aggravation of Vata Dosha are considered central to disease progression, with subsequent Srotorodha (channel obstruction) and Dhatukshaya (tissue depletion) affecting Mamsa Dhatu (muscle tissue) and Meda Dhatu (adipose tissue). Progressive impairment of tissue nourishment is therefore interpreted as contributing to muscle weakness, degeneration and loss of mobility.
- These traditional concepts offer a framework for understanding the clinical manifestations of DMD but do not replace its established genetic and molecular pathogenesis. Emerging research has also explored the application of Ayurvedic parameters, including Dosha, Dhatu, Agni and Ojas, to characterise disease stages and functional decline.
Potential role of Panchakarma and Ayurvedic therapies
Panchakarma, a group of five traditional purification procedures, has been explored for its potential supportive role in paediatric and chronic disorders. In DMD, particular attention has been directed towards Swedana (therapeutic sudation) and Basti (medicated enema). Decoction-based enemas may incorporate herbal preparations or traditionally recommended ingredients such as meat soup and black gram soup, while oil-based enemas containing clarified butter or medicated oils have been described for conditions involving muscle-tissue depletion.1
|
Ayurvedic intervention |
Traditional therapeutic rationale |
|
Pindasweda |
Medicated bolus fomentation is traditionally used to relieve stiffness, support circulation and nourish affected tissues. |
|
Matra Basti |
Oil-based enema therapy is traditionally recommended for Vata-related disorders and tissue depletion. |
|
Medicated decoction Basti |
Herbal decoctions and selected nourishing ingredients are used in traditional approaches to disorders involving Mamsa Dhatu. |
|
Oral Ayurvedic formulations |
Preparations such as Ashwagandharishta and Balaarishta have traditionally been used to support strength, nourishment and tissue metabolism. |
The potential influence of Basti on the gut microbiome and gut-brain axis has also been proposed. However, these mechanisms have not been adequately demonstrated in children with DMD, and the safety and clinical value of paediatric enemas require careful evaluation.
Emerging clinical evidence and integrative management
A recent case-based analysis evaluated an Ayurvedic treatment programme in a child with DMD over four months. The intervention involved multiple sessions of internal and external Swedana, Basti, oral herbal formulations and dietary modifications, while physiotherapy was continued. Preparations containing ingredients such as Sida cordifolia, Ashwagandha (Withania somnifera), Haritaki (Terminalia chebula), Brahmi (Bacopa monnieri) and ginger (Zingiber officinale) were included. Improvements in appetite and bowel habits were reported, alongside the ability to stand with support and subtle changes in muscle tone. These observations suggested possible benefits in selected functional and quality-of-life parameters when Ayurvedic interventions were combined with physiotherapy. However, the findings were obtained from a single case and cannot establish treatment efficacy or demonstrate that disease progression was altered.
Other Ayurvedic approaches have included Pindasweda and Matra Basti for manifestations described as Mamsagata Vata. Ashwagandharishta and Balaarishta have also been discussed for their proposed effects on tissue nourishment and metabolic function. Ama Pachana and Visha Nirharana, traditional concepts relating to the elimination of metabolic waste and toxins, have been invoked to explain reported biochemical changes. Nevertheless, reductions in muscle-associated enzymes, including creatine kinase-related markers, cannot independently establish reduced muscle degeneration or clinical improvement. Changes in CK-MB, in particular, should not be interpreted as proof of therapeutic benefit without appropriate clinical and cardiac assessment.
Conclusion
Ayurveda offers an emerging complementary framework for addressing selected supportive-care needs in children with DMD through traditional dietary approaches, herbal formulations and Panchakarma procedures. Preliminary case-based observations have suggested possible improvements in mobility-related activities, appetite, bowel function and overall well-being. However, the available evidence remains limited, and no Ayurvedic intervention has been demonstrated to restore dystrophin or modify the underlying genetic defect. Its use should therefore be considered only under specialist supervision and alongside established multidisciplinary DMD care, without delaying evidence-based treatment.1,2
References:
- Puja MS, Jyothy KB, Kulkarni V, et al. Potential benefits of Ayurveda in Duchenne muscular Dystrophy: A case based analysis. J Ayurveda Integr Med. 2026;17(1):101272. doi:10.1016/j.jaim.2025.101272 https://pmc.ncbi.nlm.nih.gov/articles/PMC12887656/#sec1
- Kataria A, Anjana. Ayurveda and Duchenne Muscular Dystrophy-A Holistic approach to enhancing Quality of Life. J Ayu Int Med Sci. 2025; 10(9):342-346 https://jaims.in/jaims/article/view/4736